A one-fifth dose of Bavarian Nordic’s mpox vaccine Jynneos can elicit a similar antibody response as its standard-dose regimen, according to findings presented Saturday at the European Society of ...
Vaccines Market in terms of revenue was estimated to be worth $78.0 billion in 2024 and is poised to reach $94.9 billion by 2029, growing at a CAGR of ...
By the time the U.S. placed its orders, the vaccine’s Denmark-based manufacturer, Bavarian Nordic, was unable to satisfy demand for months, the New York Times uncovered. The U.S. didn’t ...
Bavarian Nordic A/S - ADR does not currently pay a dividend. The outlook for the Pharmaceuticals sub-industry is positive as the world returns to normalcy and demand for electives ... to arise getting ...
Notes/observations - Sweden Central Bank (Riksbank) starts easing for first time since 2016, amid inflation approaching target and weaker economic activity; Sees two more cuts in ...
Going forward, we will focus on key business areas that implement a simplified organization to improve our cost structure and ...